Xrf Scientific Limited · ASX:XRF
Xrf Scientific — Investor Presentation (August 2026)
18 slides from Xrf Scientific's investor presentation, Aug 18, 2026
Slide 1: Investor Presentation August 2026
Investor Presentation August 2026
Slide 2: Our Technology: Sample Preparation
Our Technology Sample Preparation Technology Mining and Manufacturing Chemical Analysis Raw Prepared Samples Samples Minerals: Materials: Iron ore Cement Analysis Techniques: Gold Metals XRF Nickel Glass ICP Copper Ceramics Fire Assay Aluminium Research Photon Assay Bauxite Education Manganese Urani
Slide 3: Our Technology: Sample Analysis
Our Technology Sample Analysis Technologies Chemistry Methods Covered: Thermogravimetric Analysis CS/ONH Elemental Analysis pH Measurement 3
Slide 4: Orbis Laboratory Crushers
Orbis Laboratory Crushers For mineral analysis labs (XRF, ICP, Fire Assay, Photon Assay) 55x Sample Size Reduction Automated Sample Splitting Crushes 110mm drill core Creates a reference sample samples down to 2mm in a for elemental analysis. single pass. Industry leading Eliminates human errors fro
Slide 5: Lab Products: Sample Preparation Products
Lab Products Sample Preparation Products For mineral and material analysis labs (XRF, ICP) Platinum Labware X-Ray Flux Recycling service of turning used platinum products into new items Fusion Machines 5
Slide 6: Lab Products: Analytical Instruments (XRTGA 1100)
Lab Products Analytical Instruments XRTGA 1100 Thermogravimetric Analyser Used for thermal analysis of moisture, volatiles, ash, fixed carbon or loss on ignition Used in existing mining / construction material industries and new markets such as production quality control of food, plastics and agricu
Slide 7: Lab Products: CS/ONH Elemental Analysis
Lab Products Analytical Instruments CS/ONH Elemental Analysis Carbon, Sulphur, Oxygen, Nitrogen, Hydrogen Application examples: • Iron, Steel, Cobalt, Nickel, Ferroalloys, Aluminium, Magnesium: production quality control • High strength alloys: quality control for uses in industries such as space, a
Slide 8: FY26 Highlights
FY26 Highlights Strong demand from mining and industrial customers International sales growth in numerous developing markets, in particular Asia Continued strong growth in Orbis crusher sales Acquired CGA Elemental Analysis Instrument business on 23 April 2026 for upfront consideration of US
Slide 9: FY26 Financial Highlights
FY26 Financial Highlights 64,400 11,389 60,117 59,448 10,141 55,261 Revenue up 8% to $64.4m vs FY25 8,417 8,090 40,009 Adjusted NPBT* up 10% to $16.1m vs FY25 31,295 NPAT up 1% to $10.5m vs FY25 after expensing 4,511 acquisition and new international offices setup/startup 3,154 costs. Effectiv
Slide 10: Balance Sheet
Balance Sheet ($m) 2026 2025 Change Net cash position of $8.5m Cash and cash equivalents 9.5 12.2 (23%) CGA Acquisition was funded 100% in cash Trade and other receivables 9.7 10.3 (5%) and increased: Inventories 21.0 18.8 12% Inventories by $1.0m Other assets 0.7 0.6 19% Intangible assets b
Slide 11: Cash Flow Statements
Cash Flow Statements ($m) 2026 2025 Net cash inflow from operating activities 11.4 10.1 Net cash outflow from investing activities (8.1) (2.2) Net cash outflow from financing activities (6.0) (7.7) Cash at start of period 12.2 12.0 Net increase / (decrease) in cash (2.7) 0.2 Cash at end of period 9.
Slide 12: Consumables
Consumables Laboratory consumables and chemicals ($m) FY26 FY25 FY24 Overview for FY26: Sales revenue 18.1 19.3 18.8 Revenue down 6% on FY25 Change in % * (6%) 2% 11% NPBT down 6% on FY25 2H PBT of $3.8m vs 1H of $3.0m due to strong levels of NPBT 6.8 7.2 5.7 international sales in 2H Change
Slide 13: Precious Metals
Precious Metals Platinum laboratory and industrial products ($m) FY26 FY25 FY24 Overview for FY26: Sales revenue 24.6 21.5 21.5 Revenue** up 14% on FY25 Change in % * 14% 0% (1%) NPBT up 27% on FY25 Continued strong demand for recycling sales. Margins NPBT 4.5 3.5 3.6 expanded, which was dri
Slide 14: Capital Equipment
Capital Equipment Laboratory instruments and machines ($m) FY26 FY25 FY24 Overview for FY26: Sales revenue 26.3 22.6 21.8 Revenue up 17% on FY25 Change in % * 17% 4% 16% NPBT up 29% on FY25 Orbis revenue up 26% on FY25 to $8.9m. Sales driven by NPBT 5.3 4.1 4.6 customers in Australia, USA an
Slide 15: Growth Strategy for FY27
FY26 Highlights Growth Strategy for FY27 Implement CGA product line into Perth factory and commence first instrument sales in 1H27. Roll out related consumable sales strategy to existing user base Grow Orbis and xrTGA sales in significant addressable markets Continue with geographical expansio
Slide 16: Corporate Overview
Corporate Overview Dividends Shareholder Wealth EBIT Earnings Per Declared Per Share Price Market Share Capitalisation Share Financial Year $ Cents Cents $ $ 2019/20 4,602,319 2.3 1.4 0.24 32,118,193 2020/21 6,818,111 3.8 2.0 0.47 63,916,519 2021/22 8,259,768 4.5 2.5 0.57 77,458,468 2022/23 11,924,8
Slide 17: Contact Information
Contact Information Tel: (08) 9244 0600 86 Guthrie Street Osborne Park WA 6017 Vance Stazzonelli – CEO vance@xrfscientific.com 17
Slide 18: Disclaimer
Disclaimer No responsibility for contents of Investor Presentation •To the maximum extent permitted by law, XRF Scientific Limited and representatives: •make no representation, warranty or undertaking, express or implied, as to the adequacy, accuracy, completeness or reasonableness of this Investor